Fount Bio, Inc.

Fount Bio is applying proprietary advances in glycopolymer research to become the world’s first platform for building a long-lasting hyaluronic acid network within the skin via topical application. Fount’s Flī-HA™ technology overcomes both the delivery and biostability challenges of current forms of HA, that until now, have prevented the development of products that fully unleash HA’s benefits without the need for invasive injections.